Empower Your Protein and Gene Therapy Development With Multi-Capillary Electrophoresis

The biopharma industry has used capillary electrophoresis for many years to help improve the quality of biopharmaceuticals. Traditionally, scientists have utilized single capillaries or chips in these systems, requiring samples to be run in series.

However, a new multi-capillary system was recently launched, enabling scientists to parallel process eight samples simultaneously providing a positive impact in the development of cell and gene therapies and therapeutic proteins.

In this webinar, you will:

• Uncover how this system achieves CE-SDS separations of the same quality as traditional systems
• Gain an understanding of how the system designers have prioritized ease of use
• Discover how this system offers N-glycan analysis and charge variant detection
• Explore how this novel approach is accelerating the development of cell and gene therapy and vaccine products

Presenter: Dr. Stephen Lock (Senior Market Development Manager, Biopharma, SCIEX)